Accès gratuit
Numéro
Med Sci (Paris)
Volume 24, Numéro 1, Janvier 2008
Page(s) 25 - 28
Section Nouvelles
DOI https://doi.org/10.1051/medsci/200824125
Publié en ligne 15 janvier 2008
  1. Jamain S, Betancur C, Giros B, et al. La génétique de l’autisme. Med Sci (Paris) 2003; 19 : 1081–90.
  2. Persico AM, Bourgeron T. Searching for ways out of the autism maze : genetic, epigenetic and environmental clues. Trends Neurosci 2006; 29 : 349–58.
  3. Jamain S, Quach H, Betancur C, et al. Mutations of the X-linked genes encoding neuroligins NLGN3 and NLGN4 are associated with autism. Nat Genet 2003; 34 : 27–9.
  4. Chih B, Afridi SK, Clark L, Scheiffele P. Disorder-associated mutations lead to functional inactivation of neuroligins. Hum Mol Genet 2004; 13 : 1471–7.
  5. Tabuchi K, Blundell J, Etherton MR, et al. A Neuroligin-3 Mutation Implicated in Autism Increases Inhibitory Synaptic Transmission in Mice. Science 2007; 318 : 71–6.
  6. Varoqueaux F, Aramuni G, Rawson RL, et al. Neuroligins determine synapse maturation and function. Neuron 2006; 51 : 741–54.
  7. Talebizadeh Z, Lam DY, Theodoro MF, et al. Novel splice isoforms for NLGN3 and NLGN4 with possible implications in autism. J Med Genet 2006; 43 : e21.
  8. Laumonnier F, Bonnet-Brilhault F, Gomot M, et al. X-linked mental retardation and autism are associated with a mutation in the NLGN4 gene, a member of the neuroligin family. Am J Hum Genet 2004; 74 : 552–7.
  9. Yan J, Oliveira G, Coutinho A, et al. Analysis of the neuroligin 3 and 4 genes in autism and other neuropsychiatric patients. Mol Psychiatry 2005; 10 : 329–32.
  10. Vincent JB, Kolozsvari D, Roberts WS, et al. Mutation screening of X-chromosomal neuroligin genes : no mutations in 196 autism probands. Am J Med Genet B Neuropsychiatr Genet 2004; 129 : 82–4.
  11. Gauthier J, Bonnel A, St-Onge J, et al. NLGN3/NLGN4 gene mutations are not responsible for autism in the Quebec population. Am J Med Genet B Neuropsychiatr Genet 2005; 132 : 74–5.
  12. Blasi F, Bacchelli E, Pesaresi G, et al. Absence of coding mutations in the X-linked genes neuroligin 3 and neuroligin 4 in individuals with autism from the IMGSAC collection. Am J Med Genet B Neuropsychiatr Genet 2006; 141 : 220–1.
  13. Szatmari P, Paterson AD, Zwaigenbaum L, et al. Mapping autism risk loci using genetic linkage and chromosomal rearrangements. Nat Genet 2007; 39 : 319–28.
  14. Manning MA, Cassidy SB, Clericuzio C, et al. Terminal 22q deletion syndrome : a newly recognized cause of speech and language disability in the autism spectrum. Pediatrics 2004; 114 : 451–7.
  15. Bonaglia MC, Giorda R, Borgatti R, et al. Disruption of the ProSAP2 gene in a t(12;22)(q24.1;q13.3) is associated with the 22q13.3 deletion syndrome. Am J Hum Genet 2001; 69 : 261–8.
  16. Durand CM, Betancur C, Boeckers TM, et al. Mutations in the gene encoding the synaptic scaffolding protein SHANK3 are associated with autism spectrum disorders. Nat Genet 2007; 39 : 25–7.
  17. Roussignol G, Ango F, Romorini S, et al. Shank expression is sufficient to induce functional dendritic spine synapses in aspiny neurons. J Neurosci 2005; 25 : 3560–70.
  18. Belmonte MK, Bourgeron T. Fragile X syndrome and autism at the intersection of genetic and neural networks. Nat Neurosci 2006; 9 : 1221–5.
  19. Melke J, Goubran Botros H, et al. Abnormal melatonin synthesis in autism spectrum disorders. Mol Psychiatry 2007 15 mai online.

Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.

Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.

Le chargement des statistiques peut être long.